DEA Proposes Limits on Telehealth Prescriptions of Controlled Substances
The US Drug Enforcement Administration (DEA) has released proposed rules governing telehealth-based prescribing that extend some telehealth flexibilities but reinstate previous rules related to the virtual prescription of some controlled substances following the COVID-19 public health emergency (PHE). At the beginning of the COVID-19 pandemic, various policy changes led to a higher level of leniency in the